Results 11 to 20 of about 59,535 (272)

The continuing challenge of ESBLs [PDF]

open access: greenCurrent Opinion in Pharmacology, 2007
Since their first description more than 20 years ago, Escherichia coli and Klebsiella pneumoniae possessing extended-spectrum class A beta-lactamases (ESBLs) continue to thwart our best clinical efforts. In the 'early years' the most common beta-lactamases were of the TEM and SHV varieties.
Federico Pérez   +3 more
openalex   +4 more sources

CTX-M: changing the face of ESBLs in Europe [PDF]

open access: bronzeJournal of Antimicrobial Chemotherapy, 2006
Since around 2000 - earlier in Poland and Spain and later in France and the UK - dramatic shifts have occurred in the prevalence and types of extended-spectrum beta-lactamases (ESBLs) in Europe. Before this watershed, most producers were nosocomial isolates, often Klebsiella spp. or Enterobacter spp.
D. M. Livermore   +11 more
openalex   +6 more sources

Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence

open access: yesThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2021
Background The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing tremendously.
O. G. Onduru   +3 more
semanticscholar   +1 more source

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

open access: yesHematological Oncology, Volume 40, Issue 5, Page 846-856, December 2022., 2022
Abstract The impact of secondary infections (SI) on COVID‐19 outcome in patients with hematological malignancies (HM) is scarcely documented. To evaluate incidence, clinical characteristics, and outcome of SI, we analyzed the microbiologically documented SI in a large multicenter cohort of adult HM patients with COVID‐19.
Patrizia Zappasodi   +54 more
wiley   +1 more source

Antibacterial and antibiofilm activities of a traditional herbal formula against respiratory infection causing bacteria [PDF]

open access: yesAntibacterial and Antibiofilm Activities of a Traditional Herbal Formula against Respiratory Infection Causing Bacteria. Trop J Nat Prod Res. 2020; 4(9):527-534, 2021
The plants, Althaea officinalis, Tilia cordata and Psidium guaja have been used traditionally to treat respiratory infection symptoms. Flowers of A. officinalis and leaves of T. cordata and P. guaja have been used to treat cough, sore throat, catarrh, oral and pharyngeal mucosa irritation. Therefore, this study was designed to examine the antibacterial
arxiv   +1 more source

A case of sepsis‐induced cardiomyopathy successfully treated with venoarterial extracorporeal membrane oxygenation

open access: yesIJU Case Reports, Volume 6, Issue 1, Page 26-29, January 2023., 2023
Introduction Sepsis with concomitant acute pyelonephritis, secondary to urolithiasis, is common. We report a case of sepsis‐induced cardiomyopathy with acute pyelonephritis, successfully managed with venoarterial extracorporeal membrane oxygenation. Case presentation A 64‐year‐old woman presented with fever and disturbed consciousness.
Keigo Sato   +8 more
wiley   +1 more source

Antibiotic Resistance Pattern of Pseudomonas aeruginosa Isolated from Clinical Specimens from a Tertiary Care Centre in Central Kerala with Special Reference to Carbapenemase Detection

open access: yesJournal of Pure and Applied Microbiology, 2021
Pseudomonas aeruginosa is inherently resistant to many drugs. It is now an emerging opportunistic pathogen of clinical relevance. The emergence of carbapenemases is another major concern.
P.M. Anooja, Anu P. John
doaj   +1 more source

ESBLs: A Clear and Present Danger? [PDF]

open access: yesCritical Care Research and Practice, 2012
Extended spectrumβ-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden ...
John Clark, Rishi H‐P Dhillon
openaire   +4 more sources

Characterization of ESBL-Producing Enterobacteria from Fruit Bats in an Unprotected Area of Makokou, Gabon

open access: yesMicroorganisms, 2020
In Gabon, terrestrial mammals of protected areas have been identified as a possible source of antibiotic-resistant bacteria. Some studies on antibiotic resistance in bats have already been carried out.
Pierre Philippe Mbehang Nguema   +10 more
doaj   +1 more source

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

open access: yesClinical Infectious Diseases, 2020
BACKGROUND Antimicrobial-resistant infections are commonly encountered in US hospitals and result in significant morbidity and mortality. This guidance document provides recommendations for the treatment of infections caused by extended-spectrum β ...
P. Tamma   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy